vs
Apellis Pharmaceuticals, Inc.（APLS）与Holley Inc.（HLLY）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Holley Inc.的1.3倍（$199.9M vs $155.4M），Holley Inc.净利率更高（4.1% vs -29.5%，领先33.5%），Holley Inc.同比增速更快（11.0% vs -5.9%），Holley Inc.自由现金流更多（$3.8M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -1.0%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
霍利性能产品是一家主营汽车性能升级配件的企业，总部位于肯塔基州鲍灵格林。该公司由乔治·霍利与厄尔·霍利在1896年创立于宾夕法尼亚州布拉福德，早年扎根密歇根州时，曾是底特律多家整车厂主要的化油器供应商。
APLS vs HLLY — 直观对比
营收规模更大
APLS
是对方的1.3倍
$155.4M
营收增速更快
HLLY
高出16.9%
-5.9%
净利率更高
HLLY
高出33.5%
-29.5%
自由现金流更多
HLLY
多$18.1M
$-14.3M
两年增速更快
APLS
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $155.4M |
| 净利润 | $-59.0M | $6.3M |
| 毛利率 | — | 46.8% |
| 营业利润率 | -25.6% | 12.7% |
| 净利率 | -29.5% | 4.1% |
| 营收同比 | -5.9% | 11.0% |
| 净利润同比 | -62.2% | 116.7% |
| 每股收益（稀释后） | $-0.40 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSHLLY
| Q4 25 | $199.9M | $155.4M | ||
| Q3 25 | $458.6M | $138.4M | ||
| Q2 25 | $178.5M | $166.7M | ||
| Q1 25 | $166.8M | $153.0M | ||
| Q4 24 | $212.5M | $140.1M | ||
| Q3 24 | $196.8M | $134.0M | ||
| Q2 24 | $199.7M | $169.5M | ||
| Q1 24 | $172.3M | $158.6M |
净利润APLSHLLY
| Q4 25 | $-59.0M | $6.3M | ||
| Q3 25 | $215.7M | $-806.0K | ||
| Q2 25 | $-42.2M | $10.9M | ||
| Q1 25 | $-92.2M | $2.8M | ||
| Q4 24 | $-36.4M | $-37.8M | ||
| Q3 24 | $-57.4M | $-6.3M | ||
| Q2 24 | $-37.7M | $17.1M | ||
| Q1 24 | $-66.4M | $3.7M |
毛利率APLSHLLY
| Q4 25 | — | 46.8% | ||
| Q3 25 | — | 43.2% | ||
| Q2 25 | — | 41.7% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 45.6% | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | — | 41.5% | ||
| Q1 24 | — | 32.8% |
营业利润率APLSHLLY
| Q4 25 | -25.6% | 12.7% | ||
| Q3 25 | 48.7% | 11.5% | ||
| Q2 25 | -18.6% | 16.5% | ||
| Q1 25 | -50.0% | 12.6% | ||
| Q4 24 | -12.3% | -20.7% | ||
| Q3 24 | -24.0% | 4.2% | ||
| Q2 24 | -14.7% | 16.4% | ||
| Q1 24 | -36.0% | 6.4% |
净利率APLSHLLY
| Q4 25 | -29.5% | 4.1% | ||
| Q3 25 | 47.0% | -0.6% | ||
| Q2 25 | -23.6% | 6.5% | ||
| Q1 25 | -55.3% | 1.8% | ||
| Q4 24 | -17.1% | -27.0% | ||
| Q3 24 | -29.2% | -4.7% | ||
| Q2 24 | -18.9% | 10.1% | ||
| Q1 24 | -38.5% | 2.4% |
每股收益（稀释后）APLSHLLY
| Q4 25 | $-0.40 | $0.06 | ||
| Q3 25 | $1.67 | $-0.01 | ||
| Q2 25 | $-0.33 | $0.09 | ||
| Q1 25 | $-0.74 | $0.02 | ||
| Q4 24 | $-0.30 | $-0.32 | ||
| Q3 24 | $-0.46 | $-0.05 | ||
| Q2 24 | $-0.30 | $0.14 | ||
| Q1 24 | $-0.54 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $37.2M |
| 总债务越低越好 | — | $516.1M |
| 股东权益账面价值 | $370.1M | $448.9M |
| 总资产 | $1.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | 1.15× |
8季度趋势，按日历期对齐
现金及短期投资APLSHLLY
| Q4 25 | $466.2M | $37.2M | ||
| Q3 25 | $479.2M | $50.7M | ||
| Q2 25 | $370.0M | $63.8M | ||
| Q1 25 | $358.4M | $39.1M | ||
| Q4 24 | $411.3M | $56.1M | ||
| Q3 24 | $396.9M | $50.8M | ||
| Q2 24 | $360.1M | $53.1M | ||
| Q1 24 | $325.9M | $41.1M |
总债务APLSHLLY
| Q4 25 | — | $516.1M | ||
| Q3 25 | — | $528.9M | ||
| Q2 25 | — | $543.3M | ||
| Q1 25 | — | $551.3M | ||
| Q4 24 | — | $545.4M | ||
| Q3 24 | — | $556.4M | ||
| Q2 24 | — | $556.1M | ||
| Q1 24 | $93.1M | $567.6M |
股东权益APLSHLLY
| Q4 25 | $370.1M | $448.9M | ||
| Q3 25 | $401.2M | $439.7M | ||
| Q2 25 | $156.3M | $437.8M | ||
| Q1 25 | $164.2M | $424.6M | ||
| Q4 24 | $228.5M | $421.2M | ||
| Q3 24 | $237.1M | $458.7M | ||
| Q2 24 | $264.3M | $463.2M | ||
| Q1 24 | $266.7M | $444.9M |
总资产APLSHLLY
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $821.4M | $1.2B | ||
| Q1 25 | $807.3M | $1.1B | ||
| Q4 24 | $885.1M | $1.1B | ||
| Q3 24 | $901.9M | $1.2B | ||
| Q2 24 | $904.5M | $1.2B | ||
| Q1 24 | $831.9M | $1.2B |
负债/权益比APLSHLLY
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.30× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | 0.35× | 1.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $6.2M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $3.8M |
| 自由现金流率自由现金流/营收 | -7.1% | 2.4% |
| 资本支出强度资本支出/营收 | 0.1% | 1.5% |
| 现金转化率经营现金流/净利润 | — | 0.98× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $33.9M |
8季度趋势，按日历期对齐
经营现金流APLSHLLY
| Q4 25 | $-14.2M | $6.2M | ||
| Q3 25 | $108.5M | $7.4M | ||
| Q2 25 | $4.4M | $40.5M | ||
| Q1 25 | $-53.4M | $-7.8M | ||
| Q4 24 | $19.4M | $4.1M | ||
| Q3 24 | $34.1M | $-1.7M | ||
| Q2 24 | $-8.3M | $25.7M | ||
| Q1 24 | $-133.0M | $18.8M |
自由现金流APLSHLLY
| Q4 25 | $-14.3M | $3.8M | ||
| Q3 25 | $108.3M | $5.3M | ||
| Q2 25 | $4.4M | $35.7M | ||
| Q1 25 | $-53.4M | $-10.8M | ||
| Q4 24 | $19.3M | $1.7M | ||
| Q3 24 | — | $-3.5M | ||
| Q2 24 | $-8.4M | $24.3M | ||
| Q1 24 | $-133.3M | $17.6M |
自由现金流率APLSHLLY
| Q4 25 | -7.1% | 2.4% | ||
| Q3 25 | 23.6% | 3.8% | ||
| Q2 25 | 2.5% | 21.4% | ||
| Q1 25 | -32.0% | -7.1% | ||
| Q4 24 | 9.1% | 1.2% | ||
| Q3 24 | — | -2.6% | ||
| Q2 24 | -4.2% | 14.3% | ||
| Q1 24 | -77.3% | 11.1% |
资本支出强度APLSHLLY
| Q4 25 | 0.1% | 1.5% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.2% | 0.8% |
现金转化率APLSHLLY
| Q4 25 | — | 0.98× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 3.73× | ||
| Q1 25 | — | -2.79× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 5.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
HLLY
| Truck Off Road | $125.5M | 81% |
| Euro Import | $29.9M | 19% |
